These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 12604666)

  • 41. Morphine induces terminal micro-opioid receptor desensitization by sustained phosphorylation of serine-375.
    Schulz S; Mayer D; Pfeiffer M; Stumm R; Koch T; Höllt V
    EMBO J; 2004 Aug; 23(16):3282-9. PubMed ID: 15272312
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rapid modulation of micro-opioid receptor signaling in primary sensory neurons.
    Berg KA; Patwardhan AM; Sanchez TA; Silva YM; Hargreaves KM; Clarke WP
    J Pharmacol Exp Ther; 2007 Jun; 321(3):839-47. PubMed ID: 17347322
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pertussis-toxin-sensitive Galpha subunits selectively bind to C-terminal domain of neuronal GIRK channels: evidence for a heterotrimeric G-protein-channel complex.
    Clancy SM; Fowler CE; Finley M; Suen KF; Arrabit C; Berton F; Kosaza T; Casey PJ; Slesinger PA
    Mol Cell Neurosci; 2005 Feb; 28(2):375-89. PubMed ID: 15691717
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition by cocaine of G protein-activated inwardly rectifying K+ channels expressed in Xenopus oocytes.
    Kobayashi T; Nishizawa D; Iwamura T; Ikeda K
    Toxicol In Vitro; 2007 Jun; 21(4):656-64. PubMed ID: 17329078
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential sensitivity of N- and P/Q-type Ca2+ channel currents to a mu opioid in isolectin B4-positive and -negative dorsal root ganglion neurons.
    Wu ZZ; Chen SR; Pan HL
    J Pharmacol Exp Ther; 2004 Dec; 311(3):939-47. PubMed ID: 15280436
    [TBL] [Abstract][Full Text] [Related]  

  • 46. G-protein-gated Inwardly Rectifying Potassium Channels Modulate Respiratory Depression by Opioids.
    Montandon G; Ren J; Victoria NC; Liu H; Wickman K; Greer JJ; Horner RL
    Anesthesiology; 2016 Mar; 124(3):641-50. PubMed ID: 26675532
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Morphine and oxycodone, but not fentanyl, exhibit antinociceptive effects mediated by G-protein inwardly rectifying potassium (GIRK) channels in an oxaliplatin-induced neuropathy rat model.
    Kanbara T; Nakamura A; Shibasaki M; Mori T; Suzuki T; Sakaguchi G; Kanemasa T
    Neurosci Lett; 2014 Sep; 580():119-24. PubMed ID: 25128218
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mutation of a conserved serine in TM4 of opioid receptors confers full agonistic properties to classical antagonists.
    Claude PA; Wotta DR; Zhang XH; Prather PL; McGinn TM; Erickson LJ; Loh HH; Law PY
    Proc Natl Acad Sci U S A; 1996 Jun; 93(12):5715-9. PubMed ID: 8650158
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Agonist-induced desensitization of the mu opioid receptor-coupled potassium channel (GIRK1).
    Kovoor A; Henry DJ; Chavkin C
    J Biol Chem; 1995 Jan; 270(2):589-95. PubMed ID: 7822283
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Colocalization of mu opioid receptors with GIRK1 potassium channels in the rat brain: an immunocytochemical study.
    Bausch SB; Patterson TA; Ehrengruber MU; Lester HA; Davidson N; Chavkin C
    Recept Channels; 1995; 3(3):221-41. PubMed ID: 8821795
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Involvement of spinal G-protein inwardly rectifying potassium (GIRK) channels in the enhanced antinociceptive effects of the activation of both μ-opioid and cannabinoid CB
    Takemura Y; Sudo Y; Saeki T; Kurata S; Suzuki T; Mori T; Uezono Y
    J Pharmacol Sci; 2022 Jul; 149(3):85-92. PubMed ID: 35641032
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Kinetics of recovery from opioids at wild-type and mutant mu opioid receptors expressed in xenopus oocytes.
    Spivak CE; Beglan CL
    Synapse; 2000 Dec; 38(3):254-60. PubMed ID: 11020228
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of two C-terminal amino acids, Ser(355) and Thr(357), required for short-term homologous desensitization of mu-opioid receptors.
    Wang HL; Chang WT; Hsu CY; Huang PC; Chow YW; Li AH
    Biochem Pharmacol; 2002 Jul; 64(2):257-66. PubMed ID: 12123746
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Allelic variation S268P of the human mu-opioid receptor affects both desensitization and G protein coupling.
    Koch T; Kroslak T; Averbeck M; Mayer P; Schröder H; Raulf E; Höllt V
    Mol Pharmacol; 2000 Aug; 58(2):328-34. PubMed ID: 10908300
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Genetic analyses of morphine sensitivity].
    Ikeda K; Ogai Y; Nishizawa D; Ide S; Sora I
    Nihon Rinsho; 2005 Dec; 63 Suppl 12():463-6. PubMed ID: 16416835
    [No Abstract]   [Full Text] [Related]  

  • 56. Encoding mu-opioid receptor biased agonism with interaction fingerprints.
    Hernández-Alvarado RB; Madariaga-Mazón A; Cosme-Vela F; Marmolejo-Valencia AF; Nefzi A; Martinez-Mayorga K
    J Comput Aided Mol Des; 2021 Nov; 35(11):1081-1093. PubMed ID: 34713377
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recent Insights from Molecular Dynamics Simulations for G Protein-Coupled Receptor Drug Discovery.
    Zou Y; Ewalt J; Ng HL
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31470676
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular dynamics of fentanyl bound to μ-opioid receptor.
    Lipiński PFJ; Jarończyk M; Dobrowolski JC; Sadlej J
    J Mol Model; 2019 May; 25(5):144. PubMed ID: 31053968
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biologic mechanisms of oral cancer pain and implications for clinical therapy.
    Viet CT; Schmidt BL
    J Dent Res; 2012 May; 91(5):447-53. PubMed ID: 21972258
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endogenous opioid analgesia in peripheral tissues and the clinical implications for pain control.
    Kapitzke D; Vetter I; Cabot PJ
    Ther Clin Risk Manag; 2005 Dec; 1(4):279-97. PubMed ID: 18360571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.